{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:11:42Z","timestamp":1779120702142,"version":"3.51.4"},"reference-count":11,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:p>A retrospective chart review of 7 pubertal boys who were treated with tamoxifen was conducted to determine the effects of this therapy on skeletal maturation and predicted adult height. Tamoxifen significantly decreased the rate of skeletal maturation and increased the predicted adult height without negative effects on sexual maturation. Additional evaluation of this therapy is now required to determine if the increase in predicted adult height results in a clinically significant increase in final adult height.<\/jats:p>","DOI":"10.1542\/peds.2005-0577","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T20:44:17Z","timestamp":1133469857000},"page":"1513-1515","source":"Crossref","is-referenced-by-count":27,"title":["The Use of Tamoxifen to Improve Height Potential in Short Pubertal Boys"],"prefix":"10.1542","volume":"116","author":[{"given":"Nerissa C.","family":"Kreher","sequence":"first","affiliation":[{"name":"From the Section of Pediatric Endocrinology and Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica A.","family":"Eugster","sequence":"additional","affiliation":[{"name":"From the Section of Pediatric Endocrinology and Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Ravi","family":"Shankar","sequence":"additional","affiliation":[{"name":"From the Section of Pediatric Endocrinology and Diabetology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,12,1]]},"reference":[{"key":"2021121003231466100_R1","doi-asserted-by":"crossref","unstructured":"Mericq MV, Eggers M, Avila A, Cutler GB Jr, Cassorla F. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab.\u20082000;85:569\u2013573","DOI":"10.1210\/jc.85.2.569"},{"key":"2021121003231466100_R2","doi-asserted-by":"crossref","unstructured":"Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press; 1959","DOI":"10.1097\/00000441-195909000-00030"},{"key":"2021121003231466100_R3","doi-asserted-by":"crossref","unstructured":"Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr.\u20081952;40:423\u2013441","DOI":"10.1016\/S0022-3476(52)80205-7"},{"key":"2021121003231466100_R4","doi-asserted-by":"crossref","unstructured":"Eugster EA, Rubin SD, Reiter EO, et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr.\u20082003;143:60\u201366","DOI":"10.1016\/S0022-3476(03)00128-8"},{"key":"2021121003231466100_R5","doi-asserted-by":"crossref","unstructured":"Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab.\u20081994;78:1287\u20131292","DOI":"10.1210\/jcem.78.6.8200927"},{"key":"2021121003231466100_R6","doi-asserted-by":"crossref","unstructured":"Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man [published correction appears in N Engl J Med. 1995;332:131]. N Engl J Med.\u20081994;331:1056\u20131061","DOI":"10.1056\/NEJM199410203311604"},{"key":"2021121003231466100_R7","doi-asserted-by":"crossref","unstructured":"Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet.\u20082001;357:1743\u20131748","DOI":"10.1016\/S0140-6736(00)04895-9"},{"key":"2021121003231466100_R8","doi-asserted-by":"crossref","unstructured":"Maddalozzo J, Tenta LT, Hutchinson LR, Crawford SE, Morse DS. Juvenile fibromatosis: hormonal receptors. Int J Pediatr Otorhinolaryngol.\u20081993;25:191\u2013199","DOI":"10.1016\/0165-5876(93)90053-6"},{"key":"2021121003231466100_R9","doi-asserted-by":"crossref","unstructured":"Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr.\u20082004;145:71\u201376","DOI":"10.1016\/j.jpeds.2004.03.057"},{"key":"2021121003231466100_R10","doi-asserted-by":"crossref","unstructured":"Derman O, Kanbur NO, Kutluk T. Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health.\u20082003;15:359\u2013363","DOI":"10.1515\/IJAMH.2003.15.4.359"},{"key":"2021121003231466100_R11","doi-asserted-by":"crossref","unstructured":"Walter AW, Gajjar A, Reardon DA, et al. Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol.\u20082000;22:247\u2013251","DOI":"10.1097\/00043426-200005000-00010"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/6\/1513\/1067668\/zpe01205001513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/6\/1513\/1067668\/zpe01205001513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T10:00:21Z","timestamp":1639130421000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/6\/1513\/63013\/The-Use-of-Tamoxifen-to-Improve-Height-Potential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,12,1]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0577","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}